Albert David Limited (BOM:524075)

India flag India · Delayed Price · Currency is INR
904.25
+2.75 (0.31%)
At close: Jul 11, 2025
-29.86%
Market Cap 5.37B
Revenue (ttm) 3.46B
Net Income (ttm) 172.01M
Shares Out 5.71M
EPS (ttm) 30.14
PE Ratio 31.22
Forward PE n/a
Dividend 5.00 (0.53%)
Ex-Dividend Date Jul 25, 2025
Volume 1,274
Average Volume 1,031
Open 875.10
Previous Close 901.50
Day's Range 875.10 - 915.60
52-Week Range 763.90 - 1,752.95
Beta 0.05
RSI 66.92
Earnings Date Aug 8, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1938
Employees 1,805
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524075
Full Company Profile

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.

Financial Statements

News

There is no news available yet.